F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan.
Title | F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Sachpekidis, C., Exadaktylou P., Katsampoukas D., Moralidis E., & Arsos G. |
Journal | Hell J Nucl Med |
Volume | 23 |
Issue | 1 |
Pagination | 76-78 |
Date Published | 2020 Jan-Apr |
ISSN | 1790-5427 |
Abstract | Peritoneal lymphomatosis, defined as the disseminated intraperitoneal lymphomatous infiltration, is a rare presentation usually of non-Hodgkin lymphoma and is associated with aggressive histological subtypes of the malignancy. Recently, the term "peritoneal super scan" has been introduced in positron emission tomography/computed tomography (PET/CT) in a patient with Burkitt lymphoma to describe hypermetabolic lymphomatous involvement of the entire peritoneum, leading to suppression of tracer uptake in organs with otherwise normally increased fluorine-18-fluorodeoxyglucose (F-FDG) uptake. Herein, we report on a patient with Burkitt lymphoma, initially presenting with a peritoneal super scan in PET/CT demonstrating complete metabolic response to R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone) therapy. |
DOI | 10.1967/s002449912006 |
Alternate Journal | Hell J Nucl Med |
PubMed ID | 32222732 |